NYSE:PFE
Pfizer Inc.
- Stock
$
Share Trends
Recent Transactions
| Reporter | Filed at | Change (shares) |
|---|---|---|
| Damico Jennifer B. SVP & Controller Common Stock | 2023-03-17 | -7.74K -46.23% |
| Mcdermott Michael Executive Vice President Common Stock | 2023-02-28 | 1.953K 2.47% |
| Johnson Rady A Executive Vice President Common Stock | 2023-02-28 | 10.82K 13.06% |
| Susman Sally Executive Vice President Common Stock | 2023-02-28 | 18.12K 13.30% |
| Damico Jennifer B. SVP & Controller Common Stock | 2023-02-28 | 2.532K 15.12% |
Largest Transactions
| Reporter | Filed at | Change (shares) |
|---|---|---|
| Read Ian C Chairman & CEO Common Stock | 2018-11-06 | 1.1M 166.51% |
| Read Ian C Executive Chairman Common Stock | 2019-02-26 | -193.2K -10.85% |
| Dolsten Mikael President R&D Common Stock | 2021-11-15 | 139.9K 99.95% |
| Bourla Albert Chairman & CEO Common Stock | 2020-11-10 | -132.5K -62.87% |
| Dolsten Mikael President R&D Common Stock | 2019-02-01 | 126K 53.36% |
Transaction Log
| Reporter | Filing Date | Transaction Date | Title | T | Stock Class | price | USD | Quantity | Post Shares | delta |
|---|---|---|---|---|---|---|---|---|---|---|
| Damico Jennifer B. | 2023-03-17 | 2023-03-15 | SVP & Controller | S | Common Stock | 40.02 | -396.7K | 9.912K | 9.003K | -0.52 |
| Damico Jennifer B. | 2023-03-17 | 2023-02-24 | SVP & Controller | F | Common Stock | 41.75 | -15.03K | 360.00 | 16.38K | -0.02 |
| Damico Jennifer B. | 2023-02-28 | 2023-02-25 | SVP & Controller | F | Common Stock | 41.75 | -93.23K | 2.233K | 25.66K | -0.08 |
| Hwang Angela | 2023-02-28 | 2023-02-25 | President, Global Biopharma | F | Common Stock | 41.75 | -240K | 5.748K | 38.79K | -0.13 |
| Sahni Payal | 2023-02-28 | 2023-02-25 | Executive Vice President | M | Common Stock | 22.89 | 204.2K | 8.921K | 30.13K | 0.42 |
| Johnson Rady A | 2023-02-28 | 2023-02-25 | Executive Vice President | M | Common Stock | 22.89 | 770.3K | 33.65K | 116.5K | 0.41 |
| Sahni Payal | 2023-02-28 | 2023-02-25 | Executive Vice President | F | Common Stock | 43.44 | -172.3K | 3.967K | 24.37K | -0.14 |
| Damico Jennifer B. | 2023-02-28 | 2023-02-25 | SVP & Controller | M | Common Stock | 22.89 | 255.2K | 11.15K | 27.89K | 0.67 |
| Hwang Angela | 2023-02-28 | 2023-02-25 | President, Global Biopharma | M | Common Stock | 22.89 | 464K | 20.27K | 44.54K | 0.84 |
| Mcdermott Michael | 2023-02-28 | 2023-02-25 | Executive Vice President | F | Common Stock | 41.75 | -118.5K | 2.839K | 90.26K | -0.03 |
| Mcdermott Michael | 2023-02-28 | 2023-02-25 | Executive Vice President | F | Common Stock | 43.44 | -273.9K | 6.305K | 83.96K | -0.07 |
| Johnson Rady A | 2023-02-28 | 2023-02-25 | Executive Vice President | F | Common Stock | 43.44 | -650.1K | 14.97K | 93.64K | -0.14 |
| Susman Sally | 2023-02-28 | 2023-02-25 | Executive Vice President | F | Common Stock | 43.44 | -1.41M | 32.46K | 154.3K | -0.17 |
| Damico Jennifer B. | 2023-02-28 | 2023-02-25 | SVP & Controller | F | Common Stock | 43.44 | -215.4K | 4.958K | 20.7K | -0.19 |
| Damico Jennifer B. | 2023-02-28 | 2023-02-27 | SVP & Controller | F | Common Stock | 40.78 | -58.19K | 1.427K | 19.28K | -0.07 |
| Susman Sally | 2023-02-28 | 2023-02-25 | Executive Vice President | M | Common Stock | 22.89 | 1.671M | 72.98K | 209.2K | 0.54 |
| Susman Sally | 2023-02-28 | 2023-02-25 | Executive Vice President | F | Common Stock | 41.75 | -935.7K | 22.41K | 186.8K | -0.11 |
| Sahni Payal | 2023-02-28 | 2023-02-25 | Executive Vice President | F | Common Stock | 41.75 | -74.57K | 1.786K | 28.34K | -0.06 |
| Johnson Rady A | 2023-02-28 | 2023-02-25 | Executive Vice President | F | Common Stock | 41.75 | -328.6K | 7.87K | 108.6K | -0.07 |
| Mcdermott Michael | 2023-02-28 | 2023-02-27 | Executive Vice President | F | Common Stock | 40.78 | -125.6K | 3.081K | 80.87K | -0.04 |
| Hwang Angela | 2023-02-28 | 2023-02-25 | President, Global Biopharma | F | Common Stock | 43.44 | -391.6K | 9.015K | 29.78K | -0.23 |
| Mcdermott Michael | 2023-02-28 | 2023-02-25 | Executive Vice President | M | Common Stock | 22.89 | 324.5K | 14.18K | 93.1K | 0.18 |
| Sahni Payal | 2023-02-28 | 2023-02-27 | Executive Vice President | F | Common Stock | 40.78 | -52.89K | 1.297K | 23.08K | -0.05 |
| Sahni Payal | 2023-02-24 | 2023-02-22 | Executive Vice President | F | Common Stock | 43.70 | -404.6K | 9.259K | 21.21K | -0.30 |
| Mcdermott Michael | 2023-02-24 | 2023-02-22 | Executive Vice President | F | Common Stock | 43.70 | -354K | 8.101K | 78.92K | -0.09 |
| Johnson Rady A | 2023-02-24 | 2023-02-22 | Executive Vice President | F | Common Stock | 43.70 | -839.5K | 19.21K | 82.82K | -0.19 |
| Susman Sally | 2023-02-24 | 2023-02-22 | Executive Vice President | M | Common Stock | 30.17 | 2.294M | 76.04K | 195.5K | 0.64 |
| Johnson Rady A | 2023-02-24 | 2023-02-22 | Executive Vice President | M | Common Stock | 30.17 | 952.1K | 31.56K | 106.6K | 0.42 |
| Johnson Rady A | 2023-02-24 | 2023-02-22 | Executive Vice President | F | Common Stock | 42.38 | -191.8K | 4.526K | 102K | -0.04 |
| Mcdermott Michael | 2023-02-24 | 2023-02-22 | Executive Vice President | F | Common Stock | 42.38 | -82.01K | 1.935K | 87.02K | -0.02 |
| Susman Sally | 2023-02-24 | 2023-02-22 | Executive Vice President | F | Common Stock | 42.38 | -551.2K | 13.01K | 182.5K | -0.07 |
| Susman Sally | 2023-02-24 | 2023-02-22 | Executive Vice President | F | Common Stock | 43.70 | -2.023M | 46.29K | 136.2K | -0.25 |
| Hwang Angela | 2023-02-24 | 2023-02-22 | President, Global Biopharmaceu | F | Common Stock | 42.38 | -340.8K | 8.041K | 58.99K | -0.12 |
| Damico Jennifer B. | 2023-02-24 | 2023-02-23 | SVP & Controller | A | Common Stock | - | 0 | 3.103K | 16.74K | 0.23 |
| Sahni Payal | 2023-02-24 | 2023-02-22 | Executive Vice President | M | Common Stock | 30.17 | 458.9K | 15.21K | 32.67K | 0.87 |
| Damico Jennifer B. | 2023-02-24 | 2023-02-22 | SVP & Controller | M | Common Stock | 30.17 | 315.5K | 10.46K | 21.58K | 0.94 |
| Bourla Albert | 2023-02-24 | 2023-02-22 | Chairman & CEO | F | Common Stock | 42.38 | -2.627M | 61.99K | 352.5K | -0.15 |
| Hwang Angela | 2023-02-24 | 2023-02-22 | President, Global Biopharmaceu | M | Common Stock | 30.17 | 1.721M | 57.03K | 67.03K | 5.71 |
| Lankler Douglas M | 2023-02-24 | 2023-02-22 | Executive Vice President | F | Common Stock | 42.38 | -842.4K | 19.88K | 161.5K | -0.11 |
| Hwang Angela | 2023-02-24 | 2023-02-22 | President, Global Biopharmaceu | F | Common Stock | 43.70 | -1.517M | 34.72K | 24.27K | -0.59 |
| Damico Jennifer B. | 2023-02-24 | 2023-02-22 | SVP & Controller | F | Common Stock | 42.38 | -66.92K | 1.579K | 20.01K | -0.07 |
| Dolsten Mikael | 2023-02-24 | 2023-02-22 | President R&D | F | Common Stock | 42.38 | -1.381M | 32.59K | 391.2K | -0.08 |
| Sahni Payal | 2023-02-24 | 2023-02-22 | Executive Vice President | F | Common Stock | 42.38 | -93.49K | 2.206K | 30.47K | -0.07 |
| Mcdermott Michael | 2023-02-24 | 2023-02-22 | Executive Vice President | M | Common Stock | 30.17 | 401.5K | 13.31K | 88.96K | 0.18 |
| Damico Jennifer B. | 2023-02-24 | 2023-02-22 | SVP & Controller | F | Common Stock | 43.70 | -278.2K | 6.365K | 13.64K | -0.32 |
| Damico Jennifer B. | 2022-06-08 | 2022-06-07 | SVP & Controller | S | Common Stock | 53.96 | -227.6K | 4.218K | 10.85K | -0.28 |
| Denton David M | 2022-06-01 | 2022-05-31 | Chief Financial Officer & EVP | A | Common Stock | - | 0 | 61.28K | 62.17K | 68.85 |
| Damico Jennifer B. | 2022-05-17 | 2022-05-16 | SVP & Controller | S | Common Stock | 50.50 | -202K | 4K | 15.06K | -0.21 |
| Sahni Payal | 2022-05-16 | 2022-05-13 | Executive Vice President | S | Common Stock | 49.84 | -70.17K | 1.408K | 17.37K | -0.07 |
| Lankler Douglas M | 2022-05-13 | 2022-05-12 | Executive Vice President | S | Common Stock | 49.41 | -1.891M | 38.27K | 78.8K | -0.33 |
| Carapezzi William R Jr | 2022-05-13 | 2022-05-12 | Executive Vice President | S | Common Stock | 50.00 | -1.645M | 32.91K | 38.15K | -0.46 |
| Dolsten Mikael | 2022-05-12 | 2022-05-11 | President R&D | S | Common Stock | 49.36 | -9.872K | 200.00 | 397K | 0.00 |
| Dolsten Mikael | 2022-05-12 | 2022-05-11 | President R&D | S | Common Stock | 49.34 | -116.3K | 2.358K | 394.7K | -0.01 |
| Dolsten Mikael | 2022-05-12 | 2022-05-11 | President R&D | S | Common Stock | 49.35 | -142.7K | 2.891K | 391.8K | -0.01 |
| Susman Sally | 2022-05-12 | 2022-05-11 | Executive Vice President | G | Common Stock | - | 0 | 5K | 119.5K | -0.04 |
| Dolsten Mikael | 2022-05-12 | 2022-05-11 | President R&D | S | Common Stock | 49.32 | -915.5K | 18.56K | 365.4K | -0.05 |
| Dolsten Mikael | 2022-05-12 | 2022-05-11 | President R&D | S | Common Stock | 49.33 | -388.5K | 7.876K | 383.9K | -0.02 |
| Dolsten Mikael | 2022-05-12 | 2022-05-11 | President R&D | S | Common Stock | 49.31 | -1.579M | 32.02K | 333.3K | -0.09 |
| Pao William | 2022-04-01 | 2022-03-31 | Executive Vice President | A | Common Stock | - | 0 | 115.9K | 115.9K | 1.00 |
| Dolsten Mikael | 2022-03-04 | 2022-03-03 | President R&D | M | Common Stock | 27.34 | 1.696M | 62.02K | 356.1K | 0.21 |
| Dolsten Mikael | 2022-03-04 | 2022-03-03 | President R&D | M | Common Stock | 38.71 | 1.565M | 40.44K | 396.6K | 0.11 |
| Damelio Frank A | 2022-03-01 | 2022-02-26 | Executive Vice President | M | Common Stock | 25.60 | 3.255M | 127.2K | 649.9K | 0.24 |
| Johnson Rady A | 2022-03-01 | 2022-02-26 | Executive Vice President | F | Common Stock | 50.64 | -693.2K | 13.69K | 75K | -0.15 |
| Dolsten Mikael | 2022-03-01 | 2022-02-26 | President R&D | F | Common Stock | 47.72 | -1.419M | 29.74K | 294.1K | -0.09 |
| Bourla Albert | 2022-03-01 | 2022-02-26 | Chairman & CEO | F | Common Stock | 47.72 | -1.041M | 21.82K | 188K | -0.10 |
| Sahni Payal | 2022-03-01 | 2022-02-28 | Executive Vice President | F | Common Stock | 46.94 | -49.24K | 1.049K | 18.75K | -0.05 |
| Susman Sally | 2022-03-01 | 2022-02-26 | Executive Vice President | M | Common Stock | 25.60 | 1.628M | 63.58K | 172.9K | 0.58 |
| Damico Jennifer B. | 2022-03-01 | 2022-02-28 | SVP & Controller | F | Common Stock | 46.94 | -34.74K | 740.00 | 18.98K | -0.04 |
| Mcdermott Michael | 2022-03-01 | 2022-02-26 | Executive Vice President | M | Common Stock | 25.60 | 315.9K | 12.34K | 83.53K | 0.17 |
| Mcdermott Michael | 2022-03-01 | 2022-02-26 | Executive Vice President | F | Common Stock | 47.72 | -113.2K | 2.372K | 81.16K | -0.03 |
| Johnson Rady A | 2022-03-01 | 2022-02-26 | Executive Vice President | M | Common Stock | 25.60 | 750.5K | 29.32K | 96.2K | 0.44 |
| Susman Sally | 2022-03-01 | 2022-02-26 | Executive Vice President | F | Common Stock | 47.72 | -894.5K | 18.75K | 154.1K | -0.11 |
| Damico Jennifer B. | 2022-03-01 | 2022-02-26 | SVP & Controller | F | Common Stock | 47.72 | -89.09K | 1.867K | 24.25K | -0.07 |
| Mcdermott Michael | 2022-03-01 | 2022-02-26 | Executive Vice President | F | Common Stock | 50.64 | -291.7K | 5.761K | 75.4K | -0.07 |
| Mcdermott Michael | 2022-03-01 | 2022-02-28 | Executive Vice President | F | Common Stock | 46.94 | -64.96K | 1.384K | 74.01K | -0.02 |
| Carapezzi William R Jr | 2022-03-01 | 2022-02-26 | Executive Vice President | M | Common Stock | 25.60 | 542.5K | 21.19K | 87.36K | 0.32 |
| Carapezzi William R Jr | 2022-03-01 | 2022-02-26 | Executive Vice President | F | Common Stock | 47.72 | -220.4K | 4.619K | 82.74K | -0.05 |
| Hwang Angela | 2022-03-01 | 2022-02-26 | Group President | F | Common Stock | 47.72 | -165.2K | 3.461K | 15.93K | -0.18 |
| Carapezzi William R Jr | 2022-03-01 | 2022-02-26 | Executive Vice President | F | Common Stock | 50.64 | -501.1K | 9.895K | 72.85K | -0.12 |
| Hwang Angela | 2022-03-01 | 2022-02-26 | Group President | M | Common Stock | 25.60 | 325.5K | 12.72K | 19.39K | 1.90 |
| Johnson Rady A | 2022-03-01 | 2022-02-26 | Executive Vice President | F | Common Stock | 47.72 | -358.4K | 7.511K | 88.69K | -0.08 |
| Hwang Angela | 2022-03-01 | 2022-02-26 | Group President | F | Common Stock | 50.64 | -300.6K | 5.937K | 9.995K | -0.37 |
| Damico Jennifer B. | 2022-03-01 | 2022-02-26 | SVP & Controller | F | Common Stock | 50.64 | -229.7K | 4.535K | 19.72K | -0.19 |
| Susman Sally | 2022-03-01 | 2022-02-26 | Executive Vice President | F | Common Stock | 50.64 | -1.503M | 29.69K | 124.5K | -0.19 |
| Lankler Douglas M | 2022-03-01 | 2022-02-26 | Executive Vice President | M | Common Stock | 25.60 | 1.989M | 77.71K | 174.5K | 0.80 |
| Lankler Douglas M | 2022-03-01 | 2022-02-26 | Executive Vice President | F | Common Stock | 50.64 | -1.837M | 36.28K | 117.1K | -0.24 |
| Carapezzi William R Jr | 2022-03-01 | 2022-02-28 | Executive Vice President | F | Common Stock | 46.94 | -84.26K | 1.795K | 71.05K | -0.02 |
| Damico Jennifer B. | 2022-03-01 | 2022-02-26 | SVP & Controller | M | Common Stock | 25.60 | 248.7K | 9.713K | 26.12K | 0.59 |
| Damelio Frank A | 2022-03-01 | 2022-02-26 | Executive Vice President | F | Common Stock | 50.64 | -3.006M | 59.37K | 555.9K | -0.10 |
| Damelio Frank A | 2022-03-01 | 2022-02-26 | Executive Vice President | F | Common Stock | 47.72 | -1.651M | 34.61K | 615.3K | -0.05 |
| Lankler Douglas M | 2022-03-01 | 2022-02-26 | Executive Vice President | F | Common Stock | 47.72 | -1.009M | 21.15K | 153.4K | -0.12 |
| Bourla Albert | 2022-02-25 | 2022-02-23 | Chairman & CEO | F | Common Stock | 46.87 | -1.758M | 37.51K | 209.8K | -0.15 |
| Damico Jennifer B. | 2022-02-25 | 2022-02-23 | SVP & Controller | F | Common Stock | 46.87 | -109.6K | 2.339K | 19.33K | -0.11 |
| Damico Jennifer B. | 2022-02-25 | 2022-02-23 | SVP & Controller | M | Common Stock | 27.34 | 321.2K | 11.75K | 21.67K | 1.18 |
| Carapezzi William R Jr | 2022-02-25 | 2022-02-23 | Executive Vice President | F | Common Stock | 51.28 | -650.6K | 12.69K | 66.17K | -0.16 |
| Carapezzi William R Jr | 2022-02-25 | 2022-02-23 | Executive Vice President | M | Common Stock | 27.34 | 700.8K | 25.63K | 82.91K | 0.45 |
| Damico Jennifer B. | 2022-02-25 | 2022-02-23 | SVP & Controller | F | Common Stock | 51.28 | -298.2K | 5.815K | 13.51K | -0.30 |
| Carapezzi William R Jr | 2022-02-25 | 2022-02-23 | Executive Vice President | F | Common Stock | 46.87 | -190.2K | 4.057K | 78.86K | -0.05 |
| Damico Jennifer B. | 2022-02-25 | 2022-02-24 | SVP & Controller | A | Common Stock | - | 0 | 2.893K | 16.41K | 0.21 |
| Fonseca Lidia | 2022-02-02 | 2022-01-31 | Executive Vice President | F | Common Stock | 52.69 | -352K | 6.68K | 34.72K | -0.16 |